Jan 23, 2022 · Germ cell tumors are our next foray into these adnexal masses. They comprise 20-25% of ovarian neoplasms, can be benign or malignant, and occur generally in younger …

Jan 9, 2023 · Two FDA approved serum tumor marker panel tests, for use in women >18 years with an already identified adnexal mass that requires surgery. Serum biomarker panels may …

ABSTRACT: Adnexal masses (ie, masses of the ovary, fallopian tube, or surrounding tissues) commonly are encountered by obstetrician–gynecologists and often present diagnostic and …

Novel markers like microRNAs, DNA methylation patterns, and circulating tumor cells offer potential for enhanced diagnostic accuracy and personalized management. Integrating these …

Nov 23, 2015 · At present, CA125 remains the most important biomarker for epithelial ovarian cancer, excluding tumors of mucinous origin. Key Words: Ovarian cancer, CA125, HE4, …

Oct 1, 2019 · Table 1 summarizes which tumor markers should be considered based on the clinical setting. You should suspect an epithelial tumor if there is an adnexal mass with …

Once a diagnosis of ovarian cancer is confirmed, women should have their tumors analyzed for genetic markers which can help guide treatment options. These might include BRCA, BRAF, …

May 1, 2022 · Certain germline mutations predispose patients to heritably higher risk of breast and ovarian cancer. In particular, you have probably heard of BRCA1 and BRCA2. Others you …

Ovarian cancer tumor markers. Through utilization in screening tests, signals provided prior to clinical diagnosis and symptoms help determine the value of markers in disease detection as …

Aug 18, 2019 · On today’s episode, we start into epithelial neoplasms of the ovary, which comprise about 90% of cancers of the ovary, fallopian tube, and peritoneum. Here are the …